Decrease in sirolimus-induced proteinuria after switch to everolimus in a liver transplant recipient with diabetic nephropathy.

about

Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases.Everolimus and sirolimus in transplantation-related but different.Conversion From Sirolimus to Everolimus in Long-Term Liver Graft Recipients.

P2860

Q37760379-6EB7E1D4-89CE-4927-AD01-36A956C6195D Q38442560-A1EBFCFC-5BD4-481C-A374-F5387D60A032 Q38992157-0D9C0F2B-8E2B-4062-83B5-CAFF8F8AB34B

P2860

Decrease in sirolimus-induced proteinuria after switch to everolimus in a liver transplant recipient with diabetic nephropathy.

Item

http://www.wikidata.org/entity/Q46224052

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Decrease in sirolimus-induced ...... ent with diabetic nephropathy.

@en

Decrease in sirolimus-induced ...... ent with diabetic nephropathy.

@nl

type

Item

label

Decrease in sirolimus-induced ...... ent with diabetic nephropathy.

@en

Decrease in sirolimus-induced ...... ent with diabetic nephropathy.

@nl

prefLabel

Decrease in sirolimus-induced ...... ent with diabetic nephropathy.

@en

Decrease in sirolimus-induced ...... ent with diabetic nephropathy.

@nl

P1476

Decrease in sirolimus-induced ...... ent with diabetic nephropathy.

@en

P2093

Colette Deminière

http://www.w3.org/2001/XMLSchema#string

Jean Saric

http://www.w3.org/2001/XMLSchema#string

Karine Moreau

http://www.w3.org/2001/XMLSchema#string

Martine Neau-Cransac

http://www.w3.org/2001/XMLSchema#string

Pierre Merville

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal.

Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results.

Multidisciplinary insights on clinical guidance for the use of proliferation signal inhibitors in heart transplantation.

Everolimus versus mycophenolate mofetil in the prevention of rejection in de novo renal transplant recipients: a 3-year randomized, multicenter, phase III study.

Development of proteinuria after switch to sirolimus-based immunosuppression in long-term cardiac transplant patients.

Is sirolimus responsible for proteinuria?

Conversion from calcineurin inhibitors to sirolimus in chronic allograft dysfunction: changes in glomerular haemodynamics and proteinuria.

Proteinuria following a switch from calcineurin inhibitors to sirolimus.

Switch to everolimus for sirolimus-induced pneumonitis in a liver transplant recipient--not all proliferation signal inhibitors are the same: a case report.

P304

586-587

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1432-2277.2008.00811.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23553453

http://www.w3.org/2001/XMLSchema#string

P698

19040487

http://www.w3.org/2001/XMLSchema#string

Decrease in sirolimus-induced proteinuria after switch to everolimus in a liver transplant recipient with diabetic nephropathy.

about

P2860

P2860

Decrease in sirolimus-induced proteinuria after switch to everolimus in a liver transplant recipient with diabetic nephropathy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698